Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Puente-Marin, Sara ; Dietrich, Fabrícia ; Achenbach, Peter ; Barcenilla, Hugo ; Ludvigsson, Johnny ; Casas, Rosaura
Title:: Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
Keywords:: Immunology ; immunotherapy ; autoantigen ; GAD-alum ; type 1 diabetes ; DR3DQ2 haplotype ; intra-lymphatic treatment ; lymph node
Journal title:: Frontiers in Immunology
Year:: 2023
Journal volume:: 14
Fulltext / DOI:: doi:10.3389/fimmu.2023.1112570
Publisher:: Frontiers Media S.A.
E-ISSN:: 1664-3224
Date of publication:: 02.02.2023
CC license:: by, https://creativecommons.org/licenses/by/4.0

BibTeX

Occurrences: